Miragen Therapeutics Inc (MGEN) Stock Price & Overview
NASDAQ:MGEN
Current stock price
The current stock price of MGEN is 23.01 null. Today MGEN is down by -0.09%. In the past month the price increased by 15.69%. In the past year, price increased by 58.14%.
MGEN Key Statistics
- Market Cap
- 89.923M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -10.65
- Dividend Yield
- N/A
MGEN Stock Performance
MGEN Stock Chart
MGEN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MGEN. When comparing the yearly performance of all stocks, MGEN is one of the better performing stocks in the market, outperforming 94.92% of all stocks.
MGEN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MGEN. The financial health of MGEN is average, but there are quite some concerns on its profitability.
MGEN Earnings
MGEN Forecast & Estimates
MGEN Financial Highlights
Over the last trailing twelve months MGEN reported a non-GAAP Earnings per Share(EPS) of -10.65. The EPS decreased by -1.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1604% | ||
| ROA | -91.65% | ||
| ROE | N/A | ||
| Debt/Equity | 0.2 |
MGEN Ownership
About MGEN
Company Profile
Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.
Company Info
Miragen Therapeutics Inc
6200 LOOKOUT ROAD
BOULDER CO 80301
CEO: William S. Marshall
Phone: 720-643-5200
Miragen Therapeutics Inc / MGEN FAQ
Can you describe the business of Miragen Therapeutics Inc?
Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.
What is the stock price of Miragen Therapeutics Inc today?
The current stock price of MGEN is 23.01 null. The price decreased by -0.09% in the last trading session.
Does MGEN stock pay dividends?
MGEN does not pay a dividend.
How is the ChartMill rating for Miragen Therapeutics Inc?
MGEN has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for MGEN stock?
Miragen Therapeutics Inc (MGEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.65).
Should I buy MGEN stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MGEN.
What is the ownership structure of Miragen Therapeutics Inc (MGEN)?
You can find the ownership structure of Miragen Therapeutics Inc (MGEN) on the Ownership tab.